$FNKO

$FNKO stock is up 7% today. Here's what we see in our data.

FNKO stock rose 7% with $6.68M in trading volume. Insiders sold 17 times, bought once in 6 months. Hedge funds mixed activity. Q2 2026 revenue $207.7M, up 7.37% YoY.

Original reporting
Published Aug 28, 2026, 7:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
$FNKO stock is up 7% today. Here's what we see in our data. — source image
Decision brief

The 30-second read

$FNKONeutralLow
01

Why it matters

The combination of insider sell‑offs and hedge‑fund position changes provides a mixed signal for short‑term traders.

02

Market read

Intraday price move with insider and fund activity offers limited actionable insight.

03

What to watch

Potential upcoming product launches or licensing deals not mentioned could drive price higher.

Relevance 4/10Novelty 2/10Timing: today

Background

FNKO (Funko) is a NASDAQ‑listed company known for licensed pop‑culture collectibles.

Company-level read

Ticker impact

$FNKONeutralMedium confidence
Context

The article reports a 7% intraday price rise and details recent insider sales and hedge‑fund position changes for FNKO.

Expected impact

Potential pull‑back if selling continues; short‑term volatility expected.

Evidence & confidence

Insider sales (17 out of 18 trades) and large hedge‑fund reductions indicate possible downside risk, offset by a modest price gain.

Market effects

Limited; reflects broader volatility in consumer discretionary/collectibles space.

US market focus; no broader regional effect.

Low; primarily relevant to FNKO shareholders and short‑term traders.

Counterpoint

Despite insider sales, the 7% rally may signal a breakout if fundamentals improve.

Key entities

  • FNKO

    Funko Inc., ticker FNKO

Related articles

$FNKOHigh

Why Funko (FNKO) Stock Is Trading Up Today

Funko (FNKO) shares rose 4.9% after Seaport Research initiated coverage with a Buy rating and $8 price target, citing growth in the collector market. The stock closed at $6.88, up 5.8% from the previous close. Funko reported a profitability turnaround and raised full-year adjusted EBITDA guidance to $100–$110 million.

$FNKOMed

Funko (FNKO) Q2 2026 Earnings Call Transcript

Funko (FNKO) reported Q2 2026 net sales of $207.7M, up 7% y/y, driven by core collectibles revenue of $171.6M (+9%). Gross margin was 56.6% including a $25.4M tariff refund credit; adjusted EBITDA was $40.9M. Full-year net sales guidance is flat to up 3%, and adjusted EBITDA guidance raised to $100M-$110M.

$FNKOMedAI 8/10

Why Are Funko (FNKO) Shares Soaring Today

Funko (NASDAQ: FNKO) shares rose 8.8% intraday, closing up 11.4% at $5.88, after the company reported a profitability turnaround and raised full-year adjusted EBITDA guidance to $100–$110 million from $70–$80 million. Funko swung to adjusted EPS of $0.26 and grew revenue 7.4% to $207.7 million, citing margin improvement and a tariff-related benefit.

$FNKOHigh

Funko, Inc. (FNKO): Results of Operations and Financial Condition

Funko, Inc. (FNKO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Funko Reports Strong Second Quarter 2026 Financial Results; Reiterates Full-Year Net Sales Outlook and Raises Adjusted EBITDA Guidance --Q2 Net Sales Grew 7%; Core Collectibles Sales Increased 9%; Record Gross Margin; Adjusted EBITDA Well Above Expectation; Debt Reduced by $15M -

$NOKMed

Nokia Stock Jumps As AI, Defense Deals Drive Rerating

Nokia (NOK) stock rose 5.03% on AI and defense deals. The company's revenue is $19.22B, with a P/E of 70.7 and price-to-sales of 2.45. Rosenblatt upgraded NOK to Buy with a $15 target, citing AI and infrastructure opportunities. Recent partnerships include Telxius and C3IA, driving investor interest.

$TWSTHigh

Twist Bioscience Stock Jumps On Lilly AI Drug Discovery Deal

Twist Bioscience (TWST) stock rose 9.74% after announcing a deal with Eli Lilly for AI-driven drug discovery. The company reported $118.4M in Q3 revenue, up 23% YoY, with improved gross margins. TWST remains unprofitable but expects adjusted EBITDA breakeven in Q4. The Lilly partnership validates its technology and business model, according to the company.